MENU
BIS
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS
ProShares UltraShort Nasdaq Biotech (BIS) Ownership - Who owns ProShares UltraShort Nasdaq Biotech?
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®... Show more
Category: #Trading
Profile
Category
Trading--Inverse Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Details
Group
Alternative Funds
Category
Trading
Net Assets
4069276.00
Fund Existence
about 15 years
Turnover
N/A
Capitalization
N/A
Yield
3.50
Total Expense Ratio
0.95
Investment Style
N/A
Risk (Beta)
-1.28
Fundamentals
BIS
Net Assets
4.07M
Yield
3.50
Fund Existence
about 15 years
Total Expense Ratio
0.95
Turnover
N/A
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
-1.28
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
2.42
Assets in Top Ten Holdings
-19.44M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
4.07M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.75
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
7.00
Number of Net Holdings
13.00
Number of Short Holdings
6.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
199.94%
Gain YTD
16.170
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Trading
Profile
Fundamentals
Details
Category
Trading--Inverse Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com